Evidence map›Paper›PMID 42126450›Full record

ArticleBrain structure & function2026

Location and mapping of the human rostromedial tegmental nucleus and associated midbrain inhibitory nuclei regulating dopamine neurons.

Anastasia Filimontseva, YuHong Fu, Glenda M Halliday

Abstract read
In one paragraph

Article in Brain structure & function, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anastasia FilimontsevaBrain and Mind Centre, Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Sydney, NSW, 2050, Australia.ORCID http://orcid.org/0000-0002-3316-9035
YuHong FuBrain and Mind Centre, Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Sydney, NSW, 2050, Australia.ORCID http://orcid.org/0000-0003-4539-2039
Glenda M HallidayBrain and Mind Centre, Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Sydney, NSW, 2050, Australia. glenda.halliday@sydney.edu.au.ORCID http://orcid.org/0000-0003-0422-8398

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal experiments reveal distinct GABAergic cell clusters within the dopaminergic midbrain regions in the rostromedial tegmental nucleus (RMTg) and retrorubral fields (RRF) that have yet to be clearly defined in humans. These neurons send prominent inhibitory projections to dopaminergic neurons in the substantia nigra and ventral tegmental area that impact motor, reward and threat processing. We have identified GABAergic RMTg and RRF cell clusters in 6 μm formalin-fixed paraffin-embedded transverse human midbrain sections from ten control cases obtained from the Sydney Brain Bank using immunohistochemistry for GABA and tyrosine hydroxylase. We determined the location and cell size of RMTg and RRF GABAergic neurons, further mapping these cell clusters in transverse 50 μm thick cresyl violet stained serial midbrain sections (every 750 μm) from previously published controls (Halliday et al. 1990). GABAergic neurons were cytoarchitecturally distinct, with the largest GABAergic neurons in the RRF, followed by RMTg neurons which were larger than GABAergic neurons in the well-defined interpedunclular nucleus (Kruskal-Wallis test, p < 0.0001). RMTg and RRF GABAergic neurons first appear in caudal transverse midbrain sections approximately 38 mm above the obex. RMTg moves rostrally and medially from underneath the decussation of the superior cerebellar peduncle to just lateral to the interpeduncular nucleus. The RRF cluster also moves rostrally and medially to the parabrachial pigmented nucleus (PBP) just under the red nucleus. The GABAergic neurons in RMTg and RRF/PBP that modulate dopamine neuronal excitability have distinct morphologies in humans. Identifying these inhibitory neurons is key to evaluating their role in neurodegenerative diseases.

Indexed as

Dopaminergic NeuronsGABAergic NeuronsMesencephalonTegmentum MesencephaliAdultAgedBrain MappingFemaleHumansImmunohistochemistryMaleMiddle AgedSubstantia NigraTyrosine 3-MonooxygenaseVentral Tegmental AreaTyrosine 3-MonooxygenaseDopaminergic neuronsGABAergic neuronsParabrachial pigmented nucleusRetrorubral fieldsRostromedial tegmental nucleusThree-dimensional reconstruction

Identifiers

PMID42126450
PMCPMC13171687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.